Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate vs propofol for sedation in mechanically ventilated sepsis patients
ChiCTR2400082605Phase 4Not yet recruiting
- Sponsor
- Taizhou Hospital of Zhejiang Province
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remimazolam in sepsis (2 arms), sponsored by Taizhou Hospital of Zhejiang Province. Primary endpoint: Percentage of time within target sedation range without rescue sedation. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
sepsis
Beyond the preview
Go deeper on ChiCTR2400082605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082605.